NRX Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRXP and other ETFs, options, and stocks.About NRXP
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C.
CEOJonathan C. Javitt
CEOJonathan C. Javitt
Employees—
Employees—
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded2017
Founded2017
Employees—
Employees—
NRXP Key Statistics
Market cap62.99M
Market cap62.99M
Price-Earnings ratio-1.22
Price-Earnings ratio-1.22
Dividend yield—
Dividend yield—
Average volume470.69K
Average volume470.69K
High today$3.09
High today$3.09
Low today$2.65
Low today$2.65
Open price$2.75
Open price$2.75
Volume367.98K
Volume367.98K
52 Week high$6.01
52 Week high$6.01
52 Week low$1.12
52 Week low$1.12
Stock Snapshot
With a market cap of 62.99M, NRX Pharmaceuticals(NRXP) trades at $2.68. The stock has a price-to-earnings ratio of -1.22.
As of 2025-11-05, NRX Pharmaceuticals(NRXP) stock has fluctuated between $2.65 and $3.09. The current price stands at $2.68, placing the stock +1.1% above today's low and -13.3% off the high.
The NRX Pharmaceuticals(NRXP)'s current trading volume is 367.98K, compared to an average daily volume of 470.69K.
During the past year, NRX Pharmaceuticals(NRXP) stock moved between $1.12 at its lowest and $6.01 at its peak.
During the past year, NRX Pharmaceuticals(NRXP) stock moved between $1.12 at its lowest and $6.01 at its peak.
People also own
Based on the portfolios of people who own NRXP. This list is generated using Robinhood data, and it’s not a recommendation.